surmount-1 trial tirzepatide non-diabetic weight loss after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 Clinical trials of subcutaneous tirzepatide

It belongs to a class of drugs known as glucagon-like peptide-1 receptor agonists (GLP-1 RAs), which work by mimicking the effects of a hormone called GLP-1

at the University of Pennsylvania receives research funding from Boehringer Ingelheim, Eli Lilly and Company, Pfizer, Gila Therapeutics and Coronation Bio, which was not used to support these studies

Pharmacy verification

What to Ask Your Provider Before Drinking on Retatrutide Before drinking alcohol while taking retatrutide, it is worth having a direct conversation with your clinician

LY3298176 has the potential to deliver clinically meaningful improvement in glycaemic control and body weight